ACM
EIGR

Aquatic Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Aquatic Capital Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-77
Closed -$3K – 1862
2022
Q4 		$3K Buy
+77
New +$9.25K ﹤0.01% 1280
2022
Q2 		– Sell
-20
Closed -$5K – 1655
2022
Q1 		$5K Sell
20
-207
-91% -$32.7K 0.01% 844
2021
Q4 		$35K Buy
+227
New +$43.9K 0.07% 421

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aquatic Capital Management's EIGR Position: Q1 2023 in Review

Aquatic Capital Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 77 shares — an estimated $3K sold.

Aquatic Capital Management first reported a position in EIGR in Q4 2021 and held it in 3 quarters. The position peaked at $35K in Q4 2021. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

  • Aquatic Capital Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 77 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $3K.
  • Aquatic Capital Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's Eiger BioPharmaceuticals, Inc. position peaked at $35K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on Aquatic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.